Article Details
Retrieved on: 2025-09-22 08:44:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal Antibody Improves Motor Function in Spinal Muscular Atrophy Patients. The drug, apitegromab, is designed to inhibit myostatin activation ...
Article found on: www.technologynetworks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here